Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Ann Thorac Surg. 2018 Aug;106(2):561-566. doi: 10.1016/j.athoracsur.2018.03.044. Epub 2018 Apr 22.
Risk assessment in heart transplantation is critical for candidate selection, but current models inadequately assess individual risk of postoperative mortality. We sought to identify risk factors and develop a scoring system to predict mortality after heart transplantation in children.
The records of patients undergoing heart transplantation at our institution from 2010 through 2016 were reviewed. Clinical characteristics were recorded and compared between survivors and nonsurvivors. We used Cox proportional hazard modeling of factors associated with postoperative mortality to develop a risk factor score.
There were 74 patients who underwent heart transplantation at a mean age of 8.8 ± 6.6 years. Congenital heart disease was the most common indication, comprising 48.6% of the cohort. Overall mortality was 18.9%, with 10 of 14 dying within 30 days of the operation or during the initial postoperative admission (early mortality). Preoperative factors associated with overall mortality were single-ventricle congenital heart disease (hazard ratio [HR], 3.2; p = 0.042), biventricular assist device (HR, 4.8; p = 0.043), history of four or more sternotomies (HR, 3.9; p = 0.023), panel reactive antibody exceeding 10% (HR, 4.4; p = 0.013), any previous operation at another institution (HR, 3.2; p = 0.038), and pulmonary vein disease (HR, 4.7; p = 0.045). Each risk factor was assigned a point value, based on similar magnitude of the HRs. A score of 4 or higher predicted mortality with 57% sensitivity and 90% specificity.
In this single-center pediatric cohort, postheart transplantation mortality could be predicted using patient-specific risk factors. The cumulative effect of these risk factors predicted mortality with high specificity.
心脏移植中的风险评估对候选者的选择至关重要,但当前的模型无法充分评估术后死亡率的个体风险。我们试图确定风险因素,并开发一种评分系统来预测儿童心脏移植后的死亡率。
回顾了 2010 年至 2016 年在我院接受心脏移植的患者的病历。记录了临床特征,并比较了存活者和非存活者之间的差异。我们使用 Cox 比例风险模型对与术后死亡率相关的因素进行分析,以确定风险因素评分。
共有 74 名患者在平均年龄为 8.8 ± 6.6 岁时接受了心脏移植。先天性心脏病是最常见的适应证,占队列的 48.6%。总死亡率为 18.9%,其中 14 例中有 10 例在手术后 30 天内或在初次术后住院期间死亡(早期死亡率)。与总死亡率相关的术前因素包括单心室先天性心脏病(危险比 [HR],3.2;p=0.042)、双心室辅助装置(HR,4.8;p=0.043)、四次或以上胸骨切开术史(HR,3.9;p=0.023)、群体反应性抗体超过 10%(HR,4.4;p=0.013)、在其他机构有任何既往手术史(HR,3.2;p=0.038)和肺静脉疾病(HR,4.7;p=0.045)。根据 HR 相似的幅度,为每个风险因素分配一个分值。得分 4 分或以上可预测死亡率,其敏感性为 57%,特异性为 90%。
在这个单中心儿科队列中,可以使用患者特定的风险因素预测心脏移植后的死亡率。这些风险因素的累积效应可以高度特异性地预测死亡率。